BridgeBio Pharma
BBIO
BBIO
388 hedge funds and large institutions have $9.61B invested in BridgeBio Pharma in 2025 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 147 increasing their positions, 134 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 134
2.6% less ownership
Funds ownership: 99.44% → 96.84% (-2.6%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Holders
388
Holding in Top 10
14
Calls
$613M
Puts
$104M
Top Buyers
| 1 | +$64.6M | |
| 2 | +$58.6M | |
| 3 | +$54.6M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$51M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$50M |
Top Sellers
| 1 | -$134M | |
| 2 | -$107M | |
| 3 | -$78.2M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$35M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$34.2M |
